v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income $ 631.2 $ 23.1
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 312.4 343.8
Deferred income taxes (29.0) 2.3
Share-based compensation expense related to equity incentive plans 147.0 114.5
Amortization of debt discount 6.3 6.7
Amortization of debt issuance costs 4.6 2.7
Impairment of intangible assets 0.1 2.5
Other (5.3) 4.2
Changes in operating assets and liabilities, excluding impact of acquisitions:    
Increase in accounts receivable (66.1) (55.9)
(Increase) decrease in inventories (74.8) 201.0
Increase (decrease) in accounts payable and accrued liabilities 49.8 (26.0)
Change in other assets and liabilities (81.6) (75.8)
Change in income tax payable 36.1 (179.4)
Net cash provided by operating activities 930.7 363.7
Cash flows from investing activities:    
Other investing 0.1 1.3
Proceeds from capital-related government incentives 0.1 5.1
Investments in other assets (114.7) (50.9)
Capital expenditures (37.0) (54.4)
Net cash used in investing activities (151.5) (98.9)
Cash flows from financing activities:    
Proceeds from issuance of Commercial Paper 2,823.1 1,588.4
Repayments of Commercial Paper (2,807.6) (650.1)
Repayment of senior notes 0.0 (1,200.0)
Proceeds from sale of common stock 33.6 30.3
Tax payments related to shares withheld for vested RSUs (56.4) (20.0)
Payment of cash dividends on Series A Preferred Stock (55.6) (52.9)
Payment of cash dividends on common stock (494.5) (491.3)
Capital lease payments (0.8) (0.8)
Other financing (4.3) (3.3)
Net cash used in financing activities (562.5) (799.7)
Net increase (decrease) in cash and cash equivalents 216.7 (534.9)
Cash and cash equivalents, at beginning of period 240.3 771.7
Cash and cash equivalents, at end of period $ 457.0 $ 236.8

Source